InsiderClue
Stocks · Health care · Pharmaceutical Preparations

RIGEL PHARMACEUTICALS INC

RIGL Clue Score70
United States Fiscal year ends December CIK 0001034842
$49.08 +0.74% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $49.08 +1,314.41% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue20.4Operating income−69.7Net income−69.2Fiscal year 2017Revenue4.5 −78.0%Operating income−79.6Net income−78.0Fiscal year 2018Revenue44.5 +892.6%Operating income−72.7Net income−70.5Fiscal year 2019Revenue59.3 +33.2%Operating income−69.1Net income−66.9EPS, diluted−0.40Fiscal year 2020Revenue108.6 +83.2%Operating income−29.0Net income−29.7EPS, diluted−0.18Fiscal year 2021Revenue149.2 +37.4%Operating income−12.5Net income−17.9EPS, diluted−0.11Fiscal year 2022Revenue120.2 −19.4%Operating income−55.6Net income−58.6EPS, diluted−3.44Fiscal year 2023Revenue116.9 −2.8%Operating income−20.5Net income−25.1EPS, diluted−1.44Fiscal year 2024Revenue179.3 +53.4%Operating income24.2Net income17.5EPS, diluted0.99Fiscal year 2025Revenue294.3 +64.1%Operating income125.5Net income367.0 +1,999.1%EPS, diluted19.48
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 20.4 4.5 44.5 59.3 108.6 149.2 120.2 116.9 179.3 294.3
Growth −78.0% +892.6% +33.2% +83.2% +37.4% −19.4% −2.8% +53.4% +64.1%
Operating income −69.7 −79.6 −72.7 −69.1 −29.0 −12.5 −55.6 −20.5 24.2 125.5
Net income −69.2 −78.0 −70.5 −66.9 −29.7 −17.9 −58.6 −25.1 17.5 367.0
Growth +1,999.1%
EPS, diluted n/a n/a n/a −0.40 −0.18 −0.11 −3.44 −1.44 0.99 19.48

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−342.2%Net margin−339.6%Free cash flow margin−376.3%Fiscal year 2017Operating margin−1,775.6%Net margin−1,739.3%Free cash flow margin−1,733.3%Fiscal year 2018Operating margin−163.3%Net margin−158.3%Free cash flow margin−134.7%Fiscal year 2019Operating margin−116.5%Net margin−112.8%Free cash flow margin−72.5%Fiscal year 2020Operating margin−26.7%Net margin−27.4%Free cash flow margin−49.2%Fiscal year 2021Operating margin−8.4%Net margin−12.0%Free cash flow margin3.5%Fiscal year 2022Operating margin−46.2%Net margin−48.7%Free cash flow margin−61.7%Fiscal year 2023Operating margin−17.5%Net margin−21.5%Fiscal year 2024Operating margin13.5%Net margin9.8%Fiscal year 2025Operating margin42.6%Net margin124.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −342.2% −1,775.6% −163.3% −116.5% −26.7% −8.4% −46.2% −17.5% 13.5% 42.6%
Net margin −339.6% −1,739.3% −158.3% −112.8% −27.4% −12.0% −48.7% −21.5% 9.8% 124.7%
Free cash flow margin −376.3% −1,733.3% −134.7% −72.5% −49.2% 3.5% −61.7% n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−75.9Capital expenditure−0.8Free cash flow−76.7Fiscal year 2017Operating cash flow−77.6Capital expenditure−0.2Free cash flow−77.7Fiscal year 2018Operating cash flow−58.8Capital expenditure−1.1Free cash flow−59.9Fiscal year 2019Operating cash flow−41.5Capital expenditure−1.5Free cash flow−43.0Fiscal year 2020Operating cash flow−52.2Capital expenditure−1.3Free cash flow−53.4Fiscal year 2021Operating cash flow5.9Capital expenditure−0.6Free cash flow5.3Fiscal year 2022Operating cash flow−73.8Capital expenditure−0.5Free cash flow−74.2 −1,513.2%Fiscal year 2023Operating cash flow−5.7Fiscal year 2024Operating cash flow31.5Fiscal year 2025Operating cash flow75.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −75.9 −77.6 −58.8 −41.5 −52.2 5.9 −73.8 −5.7 31.5 75.7
Capital expenditure −0.8 −0.2 −1.1 −1.5 −1.3 −0.6 −0.5 n/a n/a n/a
Free cash flow −76.7 −77.7 −59.9 −43.0 −53.4 5.3 −74.2 n/a n/a n/a
Growth −1,513.2%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash17.6Shareholders’ equity55.0Fiscal year 2017Cash38.3Shareholders’ equity100.6Fiscal year 2018Cash76.3Shareholders’ equity109.9Fiscal year 2019Cash22.5Total debt10.0Net cash (debt)12.5Shareholders’ equity53.8Debt to equity0.19Fiscal year 2020Cash30.4Total debt20.0Net cash (debt)10.4Shareholders’ equity34.0Debt to equity0.59Fiscal year 2021Cash18.9Total debt20.0Net cash (debt)−1.1Shareholders’ equity30.4Debt to equity0.66Fiscal year 2022Cash24.5Total debt40.0Net cash (debt)−15.5Shareholders’ equity−13.6Fiscal year 2023Cash32.8Total debt60.0Net cash (debt)−27.2Shareholders’ equity−28.6Fiscal year 2024Cash56.7Total debt60.0Net cash (debt)−3.3Shareholders’ equity3.3Debt to equity18.25Fiscal year 2025Cash40.6Total debt52.5Net cash (debt)−11.9Shareholders’ equity391.5Debt to equity0.13
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 17.6 38.3 76.3 22.5 30.4 18.9 24.5 32.8 56.7 40.6
Total debt n/a n/a n/a 10.0 20.0 20.0 40.0 60.0 60.0 52.5
Net cash (debt) n/a n/a n/a 12.5 10.4 −1.1 −15.5 −27.2 −3.3 −11.9
Shareholders’ equity 55.0 100.6 109.9 53.8 34.0 30.4 −13.6 −28.6 3.3 391.5
Debt to equity n/a n/a n/a 0.19 0.59 0.66 n/a n/a 18.25 0.13

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
20.4 4.5 44.5 59.3 108.6 149.2 120.2 116.9 179.3 294.3
Growth −78.0% +892.6% +33.2% +83.2% +37.4% −19.4% −2.8% +53.4% +64.1%
n/a n/a 0.3 0.9 0.9 1.1 1.7 7.1 18.6 19.6
n/a n/a n/a n/a n/a n/a n/a 24.5 23.4 33.3
20.9 37.8 70.0 74.6 76.6 91.9 112.5 105.7 113.1 115.9
−69.7 −79.6 −72.7 −69.1 −29.0 −12.5 −55.6 −20.5 24.2 125.5
Growth +418.6%
n/a n/a n/a −66.9 −29.7 −17.3 −58.6 −25.1 18.4 121.8
0.0 0.0 0.0 n/a n/a 0.6 n/a 0.0 0.9 −245.2
−69.2 −78.0 −70.5 −66.9 −29.7 −17.9 −58.6 −25.1 17.5 367.0
Growth +1,999.1%
Per share
n/a n/a n/a −0.40 −0.18 −0.11 −3.44 −1.44 0.99 20.40
n/a n/a n/a −0.40 −0.18 −0.11 −3.44 −1.44 0.99 19.48
Growth +1,867.7%
n/a n/a n/a 167.4 168.8 170.5 17.0 17.4 17.6 18.0
n/a n/a n/a 167.4 168.8 170.5 17.0 17.4 17.7 18.8
Growth +0.8% +1.0% −90.0% +2.1% +1.6% +6.5%

† The diluted share count jumps at 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 22.1% a year over five years.
  • Operating margin is up 69.3 points on five years ago, at 42.6%.
  • A net loss in 8 of 10 years on file.